financetom
Business
financetom
/
Business
/
Trump administration sues to oust Corporation for Public Broadcasting board members
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump administration sues to oust Corporation for Public Broadcasting board members
Jul 15, 2025 4:56 PM

WASHINGTON (Reuters) -President Donald Trump's administration filed a lawsuit on Tuesday against three board members of the Corporation for Public Broadcasting who have not left their posts despite Trump's attempt to fire them.

In a complaint filed in federal court in Washington D.C., the U.S. Justice Department said Trump lawfully fired the three board members - Laura Ross, Diane Kaplan and Tom Rothman - and requested a court order ousting them.

The lawsuit is the latest twist in a larger fight between the CPB, which spends more than $500 million annually on organizations like the Public Broadcasting Service and National Public Radio, and the Trump administration.

The White House and many Republicans have argued that the government should not provide funding to support programming that they consider too liberal.

The CPB did not immediately respond to a message seeking comment from the organization and from the board members.

Created by the U.S. Congress in 1967, the CPB provides financial support for PBS, NPR, and more than 1,500 locally managed public radio and TV stations.

A Trump executive order from May aimed to slash public subsidies to PBS and NPR, which have called the move blatantly unlawful.

The CPB's directors are nominated by the president and confirmed by the Senate for six-year terms. The five current members of the board were all nominated by former President Joe Biden.

White House Deputy Director of Presidential Personnel Trent Morse sent emails to Rothman, Ross, and Kaplan in April saying they had been terminated from their posts.

The CPB responded by filing its own lawsuit, saying that "because the president has no authority over the CPB, he has no authority to terminate its board members as he has purported to do here."

U.S. District Judge Randolph Moss, who is hearing that case, ruled last month that the three board members can keep their seats, even as he denied the CPB an injunction blocking Trump from removing them.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fiserv Stock Tumbles As Outlook Softens Despite Deal With TD
Fiserv Stock Tumbles As Outlook Softens Despite Deal With TD
Jul 23, 2025
Fiserv, Inc ( FI )  stock tumbled Wednesday after it reported fiscal second-quarter 2025 results. The company reported quarterly revenue growth of 8% year-over-year to $5.52 billion, beating the analyst consensus estimate of $5.20 billion. Growth was 10% in the Merchant Solutions segment and 7% in the Financial Solutions segment. Adjusted revenue increased 8% year-over-year to $5.20 billion.  The financial technology and services provider's adjusted EPS of $2.47 beat the analyst consensus estimate...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Avidity Says FDA Grants Breakthrough Therapy Designation to Duchenne Muscular Dystrophy Treatment
Avidity Says FDA Grants Breakthrough Therapy Designation to Duchenne Muscular Dystrophy Treatment
Jul 23, 2025
09:46 AM EDT, 07/23/2025 (MT Newswires) -- Avidity Biosciences ( RNA ) said Wednesday that the US Food and Drug Administration has granted breakthrough therapy designation to delpacibart zotadirsen for the treatment of Duchenne muscular dystrophy. The biopharmaceutical company said that it remains on track to submit a biologics license application for the treatment by the end of the year....
Thermo Fisher raises annual profit forecast on resilient demand for its tools and services
Thermo Fisher raises annual profit forecast on resilient demand for its tools and services
Jul 23, 2025
July 23 (Reuters) - Thermo Fisher on Wednesday raised the lower end of its annual profit forecast, banking on strong demand for its tools and services used in drug development and said the tariff situation was improving. Shares of the company were up 10% in early trading. As some of the trade tensions show signs of easing, peers such as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved